Mahamaya Lifesciences IPO
Mahamaya Lifesciences is a BSE SME IPO listed on the BSE SME platform, priced at ₹108–₹114 per share. The stock debuted at ₹116, delivering a listing gain of 1.8%. The IPO had a lot size of ₹1200 shares and a minimum investment of ₹2,73,600.
Mahamaya Lifesciences Limited IPO
- IPO Dates
- Nov 11, 2025 – Nov 13, 2025
- Price band
- ₹108-114 per equity share
- Minimum Investment
- ₹2,73,600
- Issue size
- ₹70.44 Cr
- Lot size
- 1200
- Allotment Date
- Nov 14, 2025
- Listing
- Nov 18, 2025
- Listing At
- BSE SME
IPO timeline
-
Nov 11, 2025
Open Date
Completed
-
Nov 13, 2025
Close Date
Completed
-
Nov 14, 2025
Allotment Date
Completed
-
Nov 18, 2025
Listing Date
Completed
Mahamaya Lifesciences IPO Subscription Details
View Subscription DetailsMahamaya Lifesciences IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Mahamaya Lifesciences IPO Essentials
Mahamaya Lifesciences IPO Details
Mahamaya Lifesciences IPO is priced at ₹108-114 per share with a total issue size of 70.44 crore. The IPO has a lot size of 1200 shares and is listed on BSE SME.
- Issue price
- ₹108-114 per equity share
- Lot size
- 1200 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 61,78,800 shares(aggregating up to ₹70.44 Cr)
- Total issue size
- 61,78,800 shares
(aggregating up to ₹70.44 crore) - Fresh issue
- 56,38,800 shares
(aggregating up to ₹64.28 crore) - Offer for sale (OFS)
- 5,40,000 shares
(aggregating up to ₹6.16 crore) - Listing at
- BSE SME
- List price
- 116.0
- Listing date
- Registrar
- Kfin Technologies Ltd
- Lead manager
-
Oneview Corporate Advisors Pvt.Ltd
Market Lot Size
Investors can bid for a minimum of 2400 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 2400 | ₹2,73,600 |
| Individual(max) | 2 | 2400 | ₹2,73,600 |
| sHNI(min) | 3 | 3600 | ₹4,10,400 |
| sHNI(max) | 7 | 8400 | ₹9,57,600 |
| sHNI(min) | 8 | 9600 | ₹10,94,400 |
Mahamaya Lifesciences IPO Reservation
Mahamaya Lifesciences IPO reservation details show category-wise allocation of shares. Out of the total 61,78,800 shares, approximately 19.03% are reserved for QIB, 14.27% for NII, 33.33% for retail investors, 5.01% for market maker, and 28.36% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 17,52,000 (28.36%) | |
| Market Maker Shares Offered | 3,09,600 (5.01%) | |
| QIB Shares Offered | 11,76,000 (19.03%) | |
| NII (HNI) Shares Offered | 11,91,600 (14.27%) | |
| bHNI > ₹10L | 5,88,000 (9.52%) | 163 |
| sHNI < ₹10L | 2,94,000 (4.76%) | 82 |
| Individual Shares Offered | 20,59,200 (33.33%) | 858 |
| Total Shares Offered | 61,78,800 (100%) |
Mahamaya Lifesciences IPO Analytics
Mahamaya Lifesciences IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Mahamaya Lifesciences IPO Subscription Status
Mahamaya Lifesciences IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 1.59x, indicating moderate demand across investor categories.
| As on | QIB / NII | Individual | Total |
|---|---|---|---|
| Shares Offered / Reserved | 11,76,000 / 8,82,000 | 20,59,200 | 41,17,200 |
|
Day 1
11-11-25 06:00 PM
|
(0.00 / 0.35) x | 0.07 x | 0.11 x |
|
Day 2
12-11-25 06:00 PM
|
(0.65 / 0.27) x | 0.20 x | 0.34 x |
|
Day 3
13-11-25 06:00 PM
|
(1.19 / 2.95) x | 1.02 x | 1.59 x |
|
Total No. of Applications
|
bHNI | sHNI | Individual |
|---|---|---|---|
| 1033 (Approx) | 0.51x | 0.77x | 1.02x |
Mahamaya Lifesciences Valuations
Earnings
- EPS Pre IPO
- ₹7.29/-
- EPS Post IPO
- ₹7.01/-
- P/E Pre IPO
- 15.65
- P/E Post IPO
- 16.25
Returns
- ROE
- 34.94%
- ROCE
- 23.15%
- RoNW
- 26.19%
- PAT Margin
- 4.84%
Fundamentals
- Debt / Equity
- 1.08
- Price / Book
- 9.40
- Market Cap
- 266.82 Cr.
Mahamaya Lifesciences Financials( In Crs.)
| 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Revenue | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| Net Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves & Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
Mahamaya Lifesciences Company & Offer Insights
About Mahamaya Lifesciences
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity.
The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs.
The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Mahamaya Lifesciences Promoter(s)
Mr. Krishnamurthy Ganesan, Mrs. Lalitha Krishnamurthy, Mr. Prashant Krishnamurthy are the company's promoters of Mahamaya Lifesciences.
Mahamaya Lifesciences IPO Issue Objectives
- •
- Purchase of Equipment for existing Formulation plant
- •
- Funding capital expenditure towards setting up of a new technical manufacturing plant
- •
- Construction of Warehouse Building and Purchase of Machinery
- •
- Funding working capital requirement of our Company
- •
- General corporate purposes
Contact Information
Contact Details
Mahamaya Lifesciences
+91-1146561474
https://www.mahamayalifesciences.com/
Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1, Delhi, New Delhi, 110020
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Frequently Asked Questions
Click any question to reveal the answer
Mahamaya Lifesciences IPO is a book-built IPO worth ₹70.44 crore. The price band is ₹108–₹114 per share. The IPO opens on Nov 11, 2025 and closes on Nov 13, 2025. It will be listed on BSE SME Platform. Kfin Technologies Ltd is the registrar.
The price band of Mahamaya Lifesciences IPO is ₹108 to ₹114 per share.
The lot size of Mahamaya Lifesciences IPO is 1200 shares.
The minimum investment for Mahamaya Lifesciences IPO is approximately ₹2,73,600 based on the upper price band .
Mahamaya Lifesciences IPO opens on Nov 11, 2025 and closes on Nov 13, 2025.
The allotment date of Mahamaya Lifesciences IPO is Nov 14, 2025.
Mahamaya Lifesciences IPO is expected to be listed on Nov 18, 2025, on BSE SME Platform.
Mahamaya Lifesciences IPO valuation snapshot: P/E 16.25, EPS ₹7.01/-, P/B 9.40, RoNW 26.19%, and market cap 266.82 Cr.
To apply for Mahamaya Lifesciences IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Mahamaya Lifesciences IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Mahamaya Lifesciences IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Mahamaya Lifesciences IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Mahamaya Lifesciences IPO allotment status on IPO Ji for quick and easy access.